Ophthotech reported $350.97M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alimera Sciences ALIM:US $ 34.75M 7.41M
Applied Genetic Technologies AGTC:US $ 70.53M 4.84M
Bioline Rx BLRX:US $ 50.94M 6.46M
Cytrx CYTR:US 6.18M 2.1M
Insmed INSM:US $ 756.14M 80.9M
Nektar Therapeutics NKTR:US $ 733.46M 62.13M
Novartis NOVN:VX 37.24B 8.48B
Ophthotech OPHT:US $ 350.97M 36.52M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M